Lexaria Bioscience Corp (LXX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 02-2020 | 11-2019 | 08-2019 | 05-2019 | 02-2019 | |
| Sales | 107 | 62 | 125 | 60 | 15 |
| Cost of Goods | 58 | 8 | 15 | 3 | 3 |
| Gross Profit | 49 | 54 | 110 | 57 | 13 |
| Operating Expenses | 1,048 | 937 | 1,133 | 1,248 | 1,166 |
| Operating Income | -998 | -883 | -1,023 | -1,192 | -1,153 |
| Other Income | 1 | -42 | -93 | 4 | 0 |
| Pre-tax Income | -997 | -925 | -1,116 | -1,188 | -1,153 |
| Net Income Continuous | -997 | -925 | -1,116 | -1,188 | -1,153 |
| Minority Interests | 47 | 17 | 38 | 16 | 5 |
| Net Income | $-950 | $-907 | $-1,078 | $-1,172 | $-1,148 |
| EPS Basic Total Ops | -0.30 | -0.30 | -0.30 | -0.30 | -0.30 |
| EPS Basic Continuous Ops | -0.30 | -0.30 | -0.30 | -0.30 | -0.30 |
| EPS Diluted Total Ops | -0.30 | -0.30 | -0.30 | -0.30 | -0.30 |
| EPS Diluted Continuous Ops | -0.30 | -0.30 | -0.30 | -0.30 | -0.30 |
| EBITDA(a) | $-970 | $-856 | $-997 | $-1,169 | $-1,143 |